Recombinant RABV G (Mazorelvimab Biosimilar) antibody

Catalog No. ABIN7488403

This anti-RABV G (Mazorelvimab Biosimilar) antibody is a CHO Cells Monoclonal antibody detecting RABV G (Mazorelvimab Biosimilar) in ELISA and WB. Suitable for Human.

Quick Overview for Recombinant RABV G (Mazorelvimab Biosimilar) antibody (ABIN7488403)

Target: RABV G (Mazorelvimab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: CHO Cells

Clonality: Monoclonal

Conjugate: This RABV G (Mazorelvimab Biosimilar) antibody is un-conjugated

Application: ELISA, Western Blotting (WB)

Grade: Research Grade

Product Details anti-RABV G (Mazorelvimab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Mazorelvimab Biosimilar - Anti-G Glycoprotein mAb

Characteristics: Antibody Type: IgG1-kappa

Purification: Recombinant antibody expressed in mammalien cells and purified.

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Buffer: PBS buffer pH 7.5

Storage: -80 °C

Storage Comment: store at -80°C

Target Details for RABV G (Mazorelvimab Biosimilar)

Target: RABV G (Mazorelvimab Biosimilar)

Target Type: Biosimilar

Background: CTB 012, CTB-012, CTB012, SYN023
Mazorelvimab (SYN023) is a combination of CTB011 and CTB012 humanized monoclonal antibodies cocktail against rabies virus (RABV). Mezagitamab binds to non-overlapping epitopes on RABV glycoprotein (G). Mezagitamab has potential application in the prevention of rabies.